GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Verastem Inc (FRA:2VSA) » Definitions » Shiller PE Ratio

Verastem (FRA:2VSA) Shiller PE Ratio : (As of Jun. 21, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Verastem Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Verastem Shiller PE Ratio Historical Data

The historical data trend for Verastem's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Verastem Shiller PE Ratio Chart

Verastem Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Verastem Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Verastem's Shiller PE Ratio

For the Biotechnology subindustry, Verastem's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Verastem's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Verastem's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Verastem's Shiller PE Ratio falls into.



Verastem Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Verastem's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Verastem's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-1.159/131.7762*131.7762
=-1.159

Current CPI (Mar. 2024) = 131.7762.

Verastem Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -4.504 100.560 -5.902
201409 -4.842 100.428 -6.353
201412 -5.158 99.070 -6.861
201503 -5.100 99.621 -6.746
201506 -4.491 100.684 -5.878
201509 -4.491 100.392 -5.895
201512 -3.525 99.792 -4.655
201603 -2.371 100.470 -3.110
201606 -2.456 101.688 -3.183
201609 -2.245 101.861 -2.904
201612 -3.640 101.863 -4.709
201703 -3.927 102.862 -5.031
201706 -3.845 103.349 -4.903
201709 -6.141 104.136 -7.771
201712 -4.360 104.011 -5.524
201803 -3.990 105.290 -4.994
201806 -3.082 106.317 -3.820
201809 -2.982 106.507 -3.690
201812 -4.008 105.998 -4.983
201903 -5.522 107.251 -6.785
201906 -6.053 108.070 -7.381
201909 -4.467 108.329 -5.434
201912 -5.508 108.420 -6.695
202003 -3.801 108.902 -4.599
202006 -1.492 108.767 -1.808
202009 0.815 109.815 0.978
202012 -1.184 109.897 -1.420
202103 -0.907 111.754 -1.069
202106 -0.996 114.631 -1.145
202109 -1.326 115.734 -1.510
202112 -0.956 117.630 -1.071
202203 -0.981 121.301 -1.066
202206 -1.334 125.017 -1.406
202209 -1.111 125.227 -1.169
202212 -0.916 125.222 -0.964
202303 -0.878 127.348 -0.909
202306 -1.265 128.729 -1.295
202309 -0.703 129.860 -0.713
202312 -0.945 129.419 -0.962
202403 -1.159 131.776 -1.159

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Verastem  (FRA:2VSA) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Verastem Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Verastem's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Verastem (FRA:2VSA) Business Description

Traded in Other Exchanges
Address
117 Kendrick Street, Suite 500, Needham, MA, USA, 02494
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

Verastem (FRA:2VSA) Headlines

No Headlines